Novel Loop-Structure-Based CD19/CD22 Dual-Target CAR-T Therapy for High-Risk Diffuse Large B-Cell Lymphoma Presenting with Hemophagocytic Lymphohistiocytosis: A Case Report

Novel Loop-Structure-Based CD19/CD22 Dual-Target CAR-T Therapy for High-Risk Diffuse Large B-Cell Lymphoma Presenting with Hemophagocytic Lymphohistiocytosis: A Case Report

Yuan Ye,1,* Shuhong Li,2,* Zhi Guo,1,* Lijun Zhao,2 Huanhuan Zhou,1 Nan Zhong,1 Mingxin He,1 Yu J Cao,2 Liqiong Liu1 1Department of Hematology, Affiliated Nanshan Hospital of Shenzhen University, Shenzhen, Guangdong, 518052, People’s Republic of China; 2State Key...

Full description

Saved in:
Bibliographic Details
Main Authors: Ye Y, Li S, Guo Z, Zhao L, Zhou H, Zhong N, He M, Cao YJ, Liu L
Format: Article
Language:English
Published: Dove Medical Press 2025-07-01
Series:Cancer Management and Research
Subjects:
Hemophagocytic lymphohistiocytosis
Diffuse large B-cell lymphoma
CD19/CD22 dual target
Chimeric antigen receptor T cells
Online Access:https://www.dovepress.com/novel-loop-structure-based-cd19cd22-dual-target-car-t-therapy-for-high-peer-reviewed-fulltext-article-CMAR
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.dovepress.com/novel-loop-structure-based-cd19cd22-dual-target-car-t-therapy-for-high-peer-reviewed-fulltext-article-CMAR

Similar Items